5301.0: Wednesday, November 15, 2000: 8:30 PM-10:00 PM | ||||
| ||||
| Invited session on some actual cost-effectiveness findings with respect to employment, criminality, subsequent substance abuse and other important results | ||||
| See individual abstracts for presenting author's disclosure statement. | ||||
| Learning Objectives: Refer to the individual abstracts for learning objectives | ||||
| William Cartwright | ||||
| Gabrielle C Denmead | ||||
| Cost in cost-effectiveness: Measuring time as a cost of treatment services A Beaston-Blaakman, MPA, MSW, D S Shepard, PhD, W Shadel, PhD | ||||
| Quantifying the non-dollar benefits of substance abuse treatment D P Bury-Maynard, MPH, PhD, D S Shepard, PhD | ||||
| Free is cost-effective: Alternative forms of aftercare D S Shepard, PhD, J McKay, PhD, C Love, PhD, H S Yeom, MA, G Strickler, MA, J Calabro, MA, D P Bury-Maynard, PhD, J Tetreault | ||||
| Lower crime: A cost-effective payoff from substance abuse treatment G Strickler, MA, D S Shepard, PhD, C Love, PhD, J McKay, PhD, H S Yeom, MA, J Calabro, MA, D P Bury-Maynard, PhD, J Tetreault | ||||
| Never too late: Cost-effectiveness of substance abuse treatment in prison C Love, PhD, D S Shepard, PHD, M Daley, PhD, K White Maynard, MA | ||||
| Sponsor: | Alcohol, Tobacco, and Other Drugs | |||
| Cosponsors: | HIV/AIDS SPIG; Mental Health | |||